Wataru Morikawa

831 total citations
17 papers, 691 citations indexed

About

Wataru Morikawa is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Wataru Morikawa has authored 17 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Surgery. Recurrent topics in Wataru Morikawa's work include Lipoproteins and Cardiovascular Health (6 papers), Protease and Inhibitor Mechanisms (6 papers) and Cell Adhesion Molecules Research (3 papers). Wataru Morikawa is often cited by papers focused on Lipoproteins and Cardiovascular Health (6 papers), Protease and Inhibitor Mechanisms (6 papers) and Cell Adhesion Molecules Research (3 papers). Wataru Morikawa collaborates with scholars based in Japan and United States. Wataru Morikawa's co-authors include Michihiko Kuwano, Mayumi Ono, Jun‐ichi Fukushi, Masakazu Sakai, Seikoh Horiuchi, Hideki Hakamata, Yuichiro SAKAMOTO, Yukihide Iwamoto, Chikateru Nozaki and Hiroshi Nakanishi and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Wataru Morikawa

16 papers receiving 676 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wataru Morikawa Japan 11 310 192 158 153 125 17 691
Ulrich Sauer Germany 17 560 1.8× 158 0.8× 90 0.6× 166 1.1× 145 1.2× 22 1.1k
Y S Kanwar United States 15 419 1.4× 107 0.6× 216 1.4× 74 0.5× 59 0.5× 23 991
Z. Kachra Canada 12 297 1.0× 53 0.3× 94 0.6× 198 1.3× 147 1.2× 17 690
Kay M. Southgate United Kingdom 14 335 1.1× 313 1.6× 117 0.7× 364 2.4× 160 1.3× 18 1.2k
Maria B. Arvelo United States 13 370 1.2× 285 1.5× 315 2.0× 289 1.9× 67 0.5× 15 855
Pia Leppänen Finland 19 458 1.5× 244 1.3× 214 1.4× 168 1.1× 48 0.4× 29 972
Robel Getachew Australia 16 447 1.4× 79 0.4× 128 0.8× 82 0.5× 68 0.5× 26 736
Yoshikazu Ishimoto Japan 15 501 1.6× 232 1.2× 572 3.6× 79 0.5× 60 0.5× 19 1.1k
Marcia Pessah France 17 678 2.2× 158 0.8× 53 0.3× 112 0.7× 89 0.7× 32 1.0k
Gerard F. Clunn United Kingdom 13 335 1.1× 129 0.7× 77 0.5× 130 0.8× 37 0.3× 20 567

Countries citing papers authored by Wataru Morikawa

Since Specialization
Citations

This map shows the geographic impact of Wataru Morikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wataru Morikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wataru Morikawa more than expected).

Fields of papers citing papers by Wataru Morikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wataru Morikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wataru Morikawa. The network helps show where Wataru Morikawa may publish in the future.

Co-authorship network of co-authors of Wataru Morikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Wataru Morikawa. A scholar is included among the top collaborators of Wataru Morikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wataru Morikawa. Wataru Morikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Soejima, Kenji, Hitomi Nakamura, Masaki Hirashima, et al.. (2006). Analysis on the Molecular Species and Concentration of Circulating ADAMTS13 in Blood. The Journal of Biochemistry. 139(1). 147–154. 56 indexed citations
2.
Hirata, Kazuho, Katsuaki Masuda, Wataru Morikawa, et al.. (2004). N‐myc downstream‐regulated gene 1 expression in injured sciatic nerves. Glia. 47(4). 325–334. 19 indexed citations
3.
Masuda, Katsuaki, Mayumi Ono, Masahiro Okamoto, et al.. (2003). Downregulation of Cap43 gene by von Hippel‐Lindau tumor suppressor protein in human renal cancer cells. International Journal of Cancer. 105(6). 803–810. 60 indexed citations
4.
Wakisaka, Yoshinobu, Akiko Furuta, Katsuaki Masuda, et al.. (2003). Cellular Distribution of NDRG1 Protein in the Rat Kidney and Brain During Normal Postnatal Development. Journal of Histochemistry & Cytochemistry. 51(11). 1515–1525. 32 indexed citations
5.
Migita, Toshiro, Yoshinao Oda, Seiji Naito, et al.. (2001). The accumulation of angiostatin-like fragments in human prostate carcinoma.. PubMed. 7(9). 2750–6. 10 indexed citations
6.
Fukushi, Jun‐ichi, Mayumi Ono, Wataru Morikawa, Yukihide Iwamoto, & Michihiko Kuwano. (2000). The Activity of Soluble VCAM-1 in Angiogenesis Stimulated by IL-4 and IL-13. The Journal of Immunology. 165(5). 2818–2823. 106 indexed citations
7.
Morikawa, Wataru, Kenji Yamamoto, Mayumi Ono, et al.. (2000). Angiostatin Generation by Cathepsin D Secreted by Human Prostate Carcinoma Cells. Journal of Biological Chemistry. 275(49). 38912–38920. 70 indexed citations
8.
Tsukuba, Takayuki, et al.. (2000). New Functional Aspects of Cathepsin D and Cathepsin E. Molecules and Cells. 10(6). 601–611. 65 indexed citations
9.
Tsukuba, Takayuki, Kuniaki Okamoto, Yoshiyuki Yasuda, et al.. (2000). New Functional Aspects of Cathepsin D and Cathepsin E. Molecules and Cells. 10(6). 601–611. 17 indexed citations
10.
Sato, Yoshihiro, Shozo Kobori, Masakazu Sakai, et al.. (1996). Lipoprotein(a) induces cell growth in rat peritoneal macrophages through inhibition of transforming growth factor-β activation. Atherosclerosis. 125(1). 15–26. 21 indexed citations
11.
Sakai, Masakazu, Akira Miyazaki, Hideki Hakamata, et al.. (1996). Reconstituted high density lipoprotein reduces the capacity of oxidatively modified low density lipoprotein to accumulate cholesteryl esters in mouse peritoneal macrophages. Atherosclerosis. 119(2). 191–202. 7 indexed citations
12.
Morikawa, Wataru, et al.. (1995). Comparison of monoclonal and polyclonal enzyme‐linked immunoabsorbent (elisa) assays for serum lp(a) and differences in reactivities to lp(a) phenotypes. Journal of Clinical Laboratory Analysis. 9(3). 173–177. 2 indexed citations
13.
Morikawa, Wataru, et al.. (1995). Measurement of Lp(a) with a two-step monoclonal competitive sandwich ELISA method. Clinical Biochemistry. 28(3). 269–275. 3 indexed citations
14.
Miyazaki, Akira, Wataru Morikawa, Takanori Takiue, et al.. (1995). Intravenous Injection of Rabbit Apolipoprotein A-I Inhibits the Progression of Atherosclerosis in Cholesterol-Fed Rabbits. Arteriosclerosis Thrombosis and Vascular Biology. 15(11). 1882–1888. 161 indexed citations
15.
Ishikawa, Akira, et al.. (1994). Validity of the Cross Test to Evaluate the Equilibrium Function Test. 21(3). 186–194.
16.
Miyazaki, Ayako, Masakazu Sakai, Hideki Hakamata, et al.. (1994). Acetylated low density lipoprotein reduces its ligand activity for the scavenger receptor after interaction with reconstituted high density lipoprotein.. Journal of Biological Chemistry. 269(7). 5264–5269. 61 indexed citations
17.
Sakai, Mashito, Atsushi Miyazaki, Hideki Hakamata, et al.. (1994). Reconstituted HLD reduces the ligand activity of oxidatively modified LDL for the macrophage scavenger receptor. Atherosclerosis. 109(1-2). 44–44. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026